NRX Pharmaceuticals, Inc. Warrant
NRXPW
NRXPW
4 hedge funds and large institutions have $4K invested in NRX Pharmaceuticals, Inc. Warrant in 2022 Q2 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 0 reducing their positions, and 2 closing their positions.
Holders
4
Holders Change
–
Holders Change %
0%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$2K |
Top Sellers
| 1 |
1
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
$0 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
YCM
1
Yakira Capital Management
Westport,
Connecticut
| $2K | 17,129 | – | – |
|
|
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $2K | 15,678 | +15,678 | New |
|
|
3
Cambridge Investment Research Advisors
Fairfield,
Iowa
| – | – | -10,000 | Closed |
|
4
Bank of America
Charlotte,
North Carolina
| – | – | -200 | Closed |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| $0 | 15 | – | – |
|
|
CFGS
6
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
7
UBS Group
Zurich,
Switzerland
| $0 | 186 | +186 | New |
|